Abstract
AbstractBACKGROUNDEssential workers are at increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We did a prospective study to estimate the yield, acceptability, and costs of workplace-based systematic SARS-CoV-2 testing of asymptomatic essential workers.METHODSWe recruited non-healthcare essential businesses, in Montréal, Canada. Mobile teams, composed of two non-healthcare professionals each, visited businesses. Consenting, asymptomatic employees provided saline gargle specimens under supervision. Mobile team members self-sampled weekly. Specimens were analyzed using reverse-transcription polymerase chain reaction (RT-PCR). If an outbreak was detected (≥2 positives), we retested all initially negative participants. We did logistic regression for factors associated with a positive test. We estimated costs ($CAD) of this strategy.RESULTSFrom 27 January to 12 March 2021, 69 essential businesses were visited. Of an estimated 2348 employees onsite, 2128 (90.6%) participated. Across 2626 tests, 53 (2.0%) were positive. Self-reported non-Caucasian ethnicity (aOR 3.7, 95% CI: 1.4-9.9) and a negative SARS-CoV-2 test before the study (0.4, 0.2-0.8) were positively and negatively associated with a positive test, respectively. Five businesses—3 manufacturing/supplier and 2 meat processing— were experiencing an outbreak. At these businesses, 40 (4.4%) of 917 participants were positive on the initial test. We repeated testing at three of these businesses over 2-3 weeks: 8/350 (2.3%) were positive on the second test, and zero were positive on the third and fourth test (148 tests); no employer reported new positives to 26 March 2021. In all other businesses, 1211 participants were tested once—5 (0.4%) were positive at three childcare enterprises, one grocery store, and one manufacturing/supplier. Per person, RT-PCR costs were $34.00 and all other costs $8.67. No mobile team member tested positive.INTERPRETATIONOnsite sampling of essential workers with saline gargle is safe, acceptable, and inexpensive. Repeat testing appeared to eliminate outbreaks. Systematic testing should be considered part of SARS-CoV-2 preventive efforts.
Publisher
Cold Spring Harbor Laboratory
Reference30 articles.
1. WHO. COVID-19 Strategic Preparedness and Response Plan [Internet]. Geneva: World Health Organization; 2021 [cited 2021 Apr 23]. Available from: https://www.who.int/publications-detail-redirect/WHO-WHE-2021.02
2. Honein MA . Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths, December 2020. MMWR Morb Mortal Wkly Rep. 2020;69.
3. Sy KTL , Martinez ME , Rader B , White LF . Socioeconomic Disparities in Subway Use and COVID-19 Outcomes in New York City. American Journal of Epidemiology. 2020 Dec 29;(kwaa277).
4. Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants
5. Public Health Agency of Canada. Individual and community-based measures to mitigate the spread of COVID-19 in Canada [Internet]. Ottawa (ON): Government of Canada; 2021 [cited 2021 Apr 23]. Available from: https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/health-professionals/public-health-measures-mitigate-covid-19.html#a3
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献